AmSurg (Nasdaq: AMSG) reported earnings on Oct. 23. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Sep. 30 (Q3), AmSurg met expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share expanded significantly.

Gross margins contracted, operating margins dropped, net margins grew.

Revenue details
 AmSurg reported revenue of $226.4 million. The eight analysts polled by S&P Capital IQ wanted to see revenue of $226.0 million on the same basis. GAAP reported sales were 16% higher than the prior-year quarter's $195.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.49. The nine earnings estimates compiled by S&P Capital IQ averaged $0.49 per share. GAAP EPS of $0.49 for Q3 were 17% higher than the prior-year quarter's $0.42 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 53.9%, 210 basis points worse than the prior-year quarter. Operating margin was 29.7%, 100 basis points worse than the prior-year quarter. Net margin was 6.8%, 10 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $237.6 million. On the bottom line, the average EPS estimate is $0.51.

Next year's average estimate for revenue is $928.3 million. The average EPS estimate is $2.01.

Investor sentiment
 The stock has a three-star rating (out of five) at Motley Fool CAPS, with 137 members out of 147 rating the stock outperform, and 10 members rating it underperform. Among 45 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 42 give AmSurg a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on AmSurg is hold, with an average price target of $28.86.